Trial Summary
What is the purpose of this trial?
This trial is testing if applying a special liquid called silver diamine fluoride (SDF) before dental procedures can help numb teeth better and reduce pain for patients with sensitive teeth due to a condition called molar-incisor hypomineralization (MIH). MIH makes teeth more sensitive and harder to treat with regular anesthesia. SDF works by blocking tiny holes in the teeth and making them stronger, which could help make dental treatments less painful. SDF has been used for many years to control early childhood cavities, stop root cavities, prevent various types of cavities, reduce tooth sensitivity, strengthen weak teeth, prevent dental erosion, detect decayed tissue during treatment, and manage infected root canals.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the drug Silver Diamine Fluoride for Molar Hypomineralization?
Is silver diamine fluoride (SDF) safe for humans?
Research on silver diamine fluoride (SDF) has looked at its use in dental care, particularly for managing cavities in children. Studies have investigated its short-term and long-term effects, and while they focus on its effectiveness, they also monitor for any adverse effects, suggesting it is generally considered safe for use in humans.25678
How is silver diamine fluoride different from other treatments for molar hypomineralization?
Silver diamine fluoride (SDF) is unique because it combines silver, which has antibacterial properties, with fluoride, which helps strengthen teeth, to stop tooth decay and promote remineralization. Unlike other treatments, SDF is applied topically and is known for its ability to arrest dental caries effectively, making it a novel option for managing molar hypomineralization.12357
Research Team
James Boynton, DDS
Principal Investigator
University of Michigan
Eligibility Criteria
This trial is for children with a condition called molar-incisor hypomineralization who need dental work done on their molars. They should be generally healthy or have mild systemic disease, able to understand English, and manageable with basic non-drug guidance or laughing gas during dental procedures.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-treatment
Application of 38% SDF or placebo to hypomineralized permanent molar
Treatment
Restorative care of the tooth following pre-treatment
Follow-up
Participants are monitored for local anesthesia efficacy and tooth sensitivity
Treatment Details
Interventions
- Placebo (Other)
- SDF (Other)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Michigan
Lead Sponsor
Marschall S. Runge
University of Michigan
Chief Executive Officer since 2015
MD, PhD
Karen McConnell
University of Michigan
Chief Medical Officer since 2020
MD